Skip to main content
. Author manuscript; available in PMC: 2018 Jan 23.
Published in final edited form as: Clin Neurophysiol. 2017 Sep 20;128(11):2286–2291. doi: 10.1016/j.clinph.2017.08.028

Fig. 3.

Fig. 3

Beta peak amplitude is significantly reduced by medication at all time points. Averaged beta peak amplitudes were significantly modulated by medication across timepoints as revealed by Wilcoxon’s signed rank tests for baseline (P < 0.001), 3 months (P < 0.001) and 8 months (P = 0.0068) conditions after FDR correction for multiple comparisons. Error bars depict S.E.M. across subjects.